216 related articles for article (PubMed ID: 2474830)
1. Immunogenicity of peptide fusions to hepatitis B virus core antigen.
Stahl SJ; Murray K
Proc Natl Acad Sci U S A; 1989 Aug; 86(16):6283-7. PubMed ID: 2474830
[TBL] [Abstract][Full Text] [Related]
2. A virulent Salmonella expressing hybrid hepatitis B virus core/pre-S genes for oral vaccination.
Schödel F; Peterson D; Hughes J; Milich DR
Vaccine; 1993; 11(2):143-8. PubMed ID: 7679864
[TBL] [Abstract][Full Text] [Related]
3. Recombinant core particles of hepatitis B virus exposing foreign antigenic determinants on their surface.
Borisova GP; Berzins I; Pushko PM; Pumpen P; Gren EJ; Tsibinogin VV; Loseva V; Ose V; Ulrich R; Siakkou H
FEBS Lett; 1989 Dec; 259(1):121-4. PubMed ID: 2480917
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity of recombinant core particles of hepatitis B virus containing epitopes of human immunodeficiency virus 1 core antigen.
Ulrich R; Borisova GP; Gren E; Berzin I; Pumpen P; Eckert R; Ose V; Siakkou H; Gren EJ; von Baehr R
Arch Virol; 1992; 126(1-4):321-8. PubMed ID: 1381912
[TBL] [Abstract][Full Text] [Related]
5. Foreign epitopes in immunodominant regions of hepatitis B core particles are highly immunogenic and conformationally restricted.
Brown AL; Francis MJ; Hastings GZ; Parry NR; Barnett PV; Rowlands DJ; Clarke BE
Vaccine; 1991 Aug; 9(8):595-601. PubMed ID: 1722937
[TBL] [Abstract][Full Text] [Related]
6. Mutated epitopes of hepatitis B surface antigen fused to the core antigen of the virus induce antibodies that react with the native surface antigen.
Shiau AL; Murray K
J Med Virol; 1997 Mar; 51(3):159-66. PubMed ID: 9139078
[TBL] [Abstract][Full Text] [Related]
7. Generation of chimeric HBc proteins with epitopes in E.coli: formation of virus-like particles and a potent inducer of antigen-specific cytotoxic immune response and anti-tumor effect in vivo.
Zhang Y; Song S; Liu C; Wang Y; Xian X; He Y; Wang J; Liu F; Sun S
Cell Immunol; 2007 May; 247(1):18-27. PubMed ID: 17707782
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus core and e antigen: immune recognition and use as a vaccine carrier moiety.
Schödel F; Peterson D; Milich D
Intervirology; 1996; 39(1-2):104-10. PubMed ID: 8957676
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus genes and their expression in E. coli.
Pasek M; Goto T; Gilbert W; Zink B; Schaller H; MacKay P; Leadbetter G; Murray K
Nature; 1979 Dec; 282(5739):575-9. PubMed ID: 399329
[TBL] [Abstract][Full Text] [Related]
10. Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein.
Clarke BE; Newton SE; Carroll AR; Francis MJ; Appleyard G; Syred AD; Highfield PE; Rowlands DJ; Brown F
Nature; 1987 Nov 26-Dec 2; 330(6146):381-4. PubMed ID: 2446137
[TBL] [Abstract][Full Text] [Related]
11. Immunological properties of hepatitis B core antigen fusion proteins.
Francis MJ; Hastings GZ; Brown AL; Grace KG; Rowlands DJ; Brown F; Clarke BE
Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2545-9. PubMed ID: 2320575
[TBL] [Abstract][Full Text] [Related]
12. Presentation and immunogenicity of viral epitopes on the surface of hybrid hepatitis B virus core particles produced in bacteria.
Clarke BE; Brown AL; Grace KG; Hastings GZ; Brown F; Rowlands DJ; Francis MJ
J Gen Virol; 1990 May; 71 ( Pt 5)():1109-17. PubMed ID: 1693163
[TBL] [Abstract][Full Text] [Related]
13. [Construction and characterization of hepatitis B surface antigen "a" epitope virus-like particles].
Chen SY; Guo MZ; Qiu F; Fei YL; Yi Y; Guo Y; Jia ZY; Yu T; Bi SL
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Feb; 24(1):30-2. PubMed ID: 20848844
[TBL] [Abstract][Full Text] [Related]
14. A recombinant hepatitis B core antigen polypeptide with the protamine-like domain deleted self-assembles into capsid particles but fails to bind nucleic acids.
Gallina A; Bonelli F; Zentilin L; Rindi G; Muttini M; Milanesi G
J Virol; 1989 Nov; 63(11):4645-52. PubMed ID: 2677399
[TBL] [Abstract][Full Text] [Related]
15. New chimaeric hepatitis B virus core particles carrying hantavirus (serotype Puumala) epitopes: immunogenicity and protection against virus challenge.
Ulrich R; Koletzki D; Lachmann S; Lundkvist A; Zankl A; Kazaks A; Kurth A; Gelderblom HR; Borisova G; Meisel H; Krüger DH
J Biotechnol; 1999 Aug; 73(2-3):141-53. PubMed ID: 10486924
[TBL] [Abstract][Full Text] [Related]
16. Stability governs the apparent expression of "particulate" hepatitis B e antigen by mutant hepatitis B virus core particles.
Seifer M; Standring DN
Virology; 1993 Sep; 196(1):70-8. PubMed ID: 7689282
[TBL] [Abstract][Full Text] [Related]
17. Specificity of humoral and cellular immune response against recombinant particles of nucleocapsid protein of human hepatitis B virus in rabbits.
Isaguliants MG; Kadoshnikov YP; Kalinina TI; Smirnov VD; Wahren B
Biochemistry (Mosc); 1998 May; 63(5):551-8. PubMed ID: 9632891
[TBL] [Abstract][Full Text] [Related]
18. Expression and immunoactivity of chimeric particulate antigens of receptor binding site-core antigen of hepatitis B virus.
Yang HJ; Chen M; Cheng T; He SZ; Li SW; Guan BQ; Zhu ZH; Gu Y; Zhang J; Xia NS
World J Gastroenterol; 2005 Jan; 11(4):492-7. PubMed ID: 15641132
[TBL] [Abstract][Full Text] [Related]
19. Recombinant Expression of Tandem-HBc Virus-Like Particles (VLPs).
Stephen SL; Beales L; Peyret H; Roe A; Stonehouse NJ; Rowlands DJ
Methods Mol Biol; 2018; 1776():97-123. PubMed ID: 29869237
[TBL] [Abstract][Full Text] [Related]
20. The effect of the structure of the terminal regions of the hepatitis B virus gene C polypeptide on the formation of core antigen (HBcAg) particles.
Khudyakov YuE ; Kalinina TI; Neplyueva VS; Gazina EV; Kadoshnikov YuP ; Bogdanova SL; Smirnov VD
Biomed Sci; 1991; 2(3):257-65. PubMed ID: 1751758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
